Modified avian pancreatic polypeptide miniature binding...

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S326000, C530S327000

Reexamination Certificate

active

09840085

ABSTRACT:
The present invention provides a protein scaffold, such as an avian pancreatic polypeptide, that can be modified by substitution of two or more amino acid residues that are exposed on the alpha helix domain of the polypeptide when the polypeptide is in a tertiary form.

REFERENCES:
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5427908 (1995-06-01), Dower et al.
patent: 5516637 (1996-05-01), Huang et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5656725 (1997-08-01), Chittenden et al.
patent: 5658727 (1997-08-01), Barbas et al.
patent: 5698426 (1997-12-01), Huse
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5750753 (1998-05-01), Kimae et al.
patent: 5780225 (1998-07-01), Wigler et al.
patent: 5821047 (1998-10-01), Garrard et al.
patent: 5837500 (1998-11-01), Ladner et al.
patent: 5969108 (1999-10-01), McCafferty et al.
Genbank Sequence Accession No. P38803, May 30, 2000.
Genbank Sequence Accession No. P43316, Dec. 15, 1998.
Agre et al., 1989, Science 246:922-926.
Ames et al., 1995, J. Immunol. Methods 184:177-186.
Andrews et al., 1999, Tetrahedron 55:11711-11743.
Armstrong et al., 1993, J. Mol. Biol. 230:284-291.
Blackwell et al., 1998, Angew. Chem. Int. Ed. 37:3281-3284.
Blundell et al., 1981, Proc. Natl. Acad. Sci. USA 78:4175-4179.
Braisted et al., 1996, Proc. Natl. Acad. Sci., USA 93:5688-5692.
Brinkmann et al., 1995, J. Immunol. Methods 182:41-50.
Burton et al., 1994, Adv. Immunol. 57:191-280.
Cohen et al., 1972, Proc. Natl. Acad. Sci. USA 69:2110-2114.
Cunningham et al., 1997, Curr. Opin. Struct. Biol. 7:457-462.
Ferré-D'Amaré et al., 1993, Nature 363:38-45.
Flanagan et al., 1998, Annu. Rev. Neurosci. 21:309-345.
Fried et al., 1981, Nucl. Acids Res. 9:6505-6525.
Graham et al., 1973, Virology 52:456-467.
Hoogenboom et al., 1991, Nucleic Acids Res. 19:4133-4137.
Jackson et al., 1991, J. Am. Chem. Soc. 113:9391-9392.
Johnson, 1993, Mol. Cell. Biol. 13:6919-6930.
Keller et al., 1995, J. Mol. Biol. 254:657-667.
Kemp et al., 1991, J. Org. Chem. 56:6683-6697.
Kettleborough et al., 1994, Eur. J. Immunol. 24:952-958.
Kouzarides et al., 1998, Nature 336:646-651.
Kussie et al., 1996, Science 274:948-953.
Li et al., 1992, Biochemistry 31:1245-1253.
Li et al., 1995, Science 270:1657-1660.
Ma et al., 1994, Cell 77:451-459.
Marks et al., 1991, J. Mol. Biol, 222:581-597.
McCafferty et al., 1990, Nature 348:552-554.
Morii et al., 1996, J. Am. Chem. Soc. 118:10011-10017.
Nygren et al., 1997, Curr. Opin. Struct. Biol. 7:463-469.
O'Neil et al., 1990, Science 249:774-778.
Park et al., 1996, J. Am. Chem. Soc. 118:4235-4239.
Persic et al., 1997, Gene 187:9-18.
Radhakrishnan et al., 1997, Cell 91:741-752.
Sattler et al., 1997, Science 275:983-986.
Sauder et al., 1996, J. Gen. Virol. 77:991-996.
Schafmeister et al.,2000, J. Am. Chem. Soc. 122:5891-5892.
Scott et al., 1984, Proc. Natl. Acad. Sci 81:4115-4119.
Segal et al.,2000, Curr. Op. Chem. Biol. 4:34-39.
Shimizu et al., 1997 EMBO J. 16:4689-4697.
Southern, 1975, J. Mol. Biol. 98:503-517.
Southern et al., 1982, J. Mol. Appl. Genet. 1:327-341.
Suckow et al., 1993, EMBO J. 12:1193-1200.
Takahashi et al., 1999, Cell 99:59-69.
Takayama et al.,1997, Methods Mol. Biol. 69:171-184.
Tonan et al., 1990, Biochemistry 29:4424-4429.
Vita et al., 1995, Proc. Natl. Acad. Sci. USA 92:6404-6408.
Vita et al., 1998, Biopolymers 47:93-100.
Weiss et al., 1990, Nature 347:575-578.
Wigler et al., 1979, Proc. Natl. Acad. Sci. USA 76:1373-1376.
Zondlo et al., 1999, J. Am. Chem. Soc. 121:6938-6939.
Akamine, P., et al., “Dynamic Features of cAMP-dependent Protein Kinase Revealed by Apoenzyme Crystal Structure,” J. Mol. Biol., 327:159-171 (2003).
Bridges, A., “Chemical Inhibitors of Protein Kinases,” Chem Rev., 101:2541-72 (2001).
Cheng, H.C., et al., “A Potent Synthetic Peptide Inhibitor of the cAMP-dependent Protein Kinase,” J. Biol. Chem., 261(3):989-992 (1986).
Chin, J. W. and Schepartz, A., “Design and Evolution of a Miniature Bcl-2 Binding Protein”, Agnew. Chem. Int. Ed., 20:3806-3809 (2001).
Chin, J.W., and Schepartz, A., “Concerted Evolution of Structure and Function in a Miniature Protein,” J. Am. Chem. Soc., 123:2929-2930 (2001).
Cohen, P., “The Development and Therapeutic Potential of Protein Kinase Inhibitors,” Current Opinion in Chemical Biology, 3:459-465 (1999).
Du, K., et al., “Characterization of a CREB Gain-of-Function Mutant with Constitutive Transcriptional Activity In Vivo,” Mol. Cell. Biol., 20:4320-4327 (2000).
Garcia-Echeverria, C., et al., “Discovery of Potent Antagonists of the Interaction between Human Double Minute 2 and Tumor Supressor p53,” J. Med. Chem., 43:3205-3208 (2000).
Glass, D., et al., “Protein Kinase Inhibitor-(6-22)-amide Peptide Analogs with Standard and Nonstandard Amino Acid Substitutions for Phenylalanine 10,” J. Biol. Chem., 264:14579-14584 (1989).
Glass, D., et al., “Differential and Common Recognition of the Catalytic Sites of the cGMP-dependent and cAMP-dependent Protein Kinases by Inhibitory Peptides Derived from the Heat-stable Inhibitor Protein,” J. Biol. Chem., 261:12166-12171 (1986).
Glass, D., et al., “Primary Structural Determinants Essential for Potent Inhibition of cAMP-dependent Protein Kinase by Inhibitory Peptides Corresponding to the Active Portion of the Heat-stable Inhibitor Protein,” J. Biol. Chem., 264:8802-8810 (1989).
Glover, I., et al., “Conformational Flexibility in a Small Globular Hormone: X-Ray Analysis of Avian Pancreatic Polypeptide at 0.98-Å Resolution,” Biopolymers, 22:293-304 (1983).
Glover, I., et al., “Crystal Structure of the Heterodimeric bZIP Transcription Factor c-Fos-c-Jun Bound to DNA,” Nature, 373:257-261 (1995).
Gonalez, G., et al., “Cyclic AMP Stimulates Somatostatin Gene Transcription by Phosphorylation of CREB at Serine 133,” Cell, 59:675-680 (1989).
Hashimoto, Y., et al., “Potent and Preferential Inhibition of Ca2+/ Calmodulin-Dependent Protein Kinase II by K252a and its Derivative, KT5926,” Biochem. Biophys. Res. Comm., 181:423-429 (1991).
Johannessen, M., et al., “Synergistic Activiation of CREB-mediated Transcription by Forskolin and Phorbol Ester Requires PKC and Depends on the Glutamine-rich Q2 Transactivation Domain,” Cell. Signal., 16:1187-1199 (2004).
Johnson, D., et al., “Dynamics of cAMP-Dependent Protein Kinase,” Chem. Rev., 101:2243-2270 (2001).
Kase, H., et al., “K-252 Compounds, Novel and Potent Inhibitors of Protein Kinase C and Cyclic Nucleotide-Dependent Protein Kinases,” Biochem. Biophys. Res. Commun., 142:436-440 (1987).
Kase, H., et al., “K-252a, A Potent Inhibitor of Protein Kinase C from Microbial Origin,” J. Antibiot., 39:1059-1065 (1986).
Kettleborough, C., et al., “Isolation of Tumor Cell-specific Single-chain Fv from Immunized Mice Using Phage-antibody Libraries and the Re-construction of Whole Antibodies from these Antibody Fragments,” Eur. J. Immunol., 24:952-958 (1994).
Knighton, D., et al., “Structure of a Peptide Inhibitor Bound to the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase,” Science, 253:414-420 (1991).
Liljas, A., et al., “Crystal Structure of Human Carbonic Anhydrase C,” Nat. New Biol., 235:131-137 (1972).
Meador, W., et al., “Target Enzyme Recognition by Calmodulin: 2.4 § Structure of a Calmodulin-Peptide Complex,” Science, 257:1251-1255 (1992).
Mestas, S. and Lumb, K., “Electrostatic Contribution of Phosphorylation to the Stability of the CREB-CBP Activator-Coactivator Complex,” Nat. Struct. Biol., 6:613-614 (1999).
Miller, W. T., “Double Trouble,” Nat. Struct. Biol., 8:16-18 (2001).
Munson, P., et al., “An Exact Correction to the ‘Cheng-Prusoff’ Correction,” J. Recept. Res., 8:533-546 (1988).
Parker, D., et

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modified avian pancreatic polypeptide miniature binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified avian pancreatic polypeptide miniature binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified avian pancreatic polypeptide miniature binding... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3811979

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.